Merck tightens manufacturing supply chain; Cheap HPV vaccines may appear without patent infringement;

> Merck is realigning its global manufacturing network to create a focused, more fully-utilized and cost-efficient worldwide supply chain. Release

> Study says vaccine makers from developing countries may be able to produce an HPV vaccine at low cost without infringing patents. Article

> Contract manufacturer AAIPharma and nanotech supplier CritiTech have allied to offer biopharma companies an alternative to conventional parenteral administration that aims to improve the delivery of molecules having low aqueous solubility or poor bioavailability. Article

> OctoPlus will perform process development and clinical manufacturing for The Medicines Co's MDCO-216 drug candidate. Announcement

> Amneal Pharmaceuticals has named Shankar Hariharan chief scientific officer/exec VP for specialty pharmaceuticals. Release

Suggested Articles

Cadila Healthcare is looking for outside manufacturing partners to add 70 million doses of its experimental COVID-19 vaccine to its arsenal.

The COVID-19 pandemic has disrupted another biopharma company's plan to launch a new medicine.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.